A detailed history of Aigen Investment Management, LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 6,734 shares of AXSM stock, worth $739,864. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,734
Previous 4,663 44.41%
Holding current value
$739,864
Previous $394,000 99.24%
% of portfolio
0.14%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025

BUY
$80.05 - $137.75 $165,783 - $285,280
2,071 Added 44.41%
6,734 $785,000
Q4 2024

Feb 06, 2025

BUY
$83.08 - $100.49 $387,402 - $468,584
4,663 New
4,663 $394,000
Q4 2023

Feb 09, 2024

BUY
$57.42 - $83.61 $221,985 - $323,236
3,866 New
3,866 $307,000
Q4 2022

Feb 10, 2023

BUY
$39.94 - $79.72 $121,657 - $242,827
3,046 New
3,046 $234,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $4.71B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.